Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited
Key Takeaways
- 2.5 mg equals 25 units on a U-100 insulin syringe when the medication concentration is 10 mg/mL.
- The conversion changes with concentration. At 5 mg/mL, 2.5 mg is 50 units. At 2.5 mg/mL, it's 100 units.
- One unit on a U-100 insulin syringe always equals 0.01 mL of liquid, regardless of what's in the vial.
- The phrase "how many units is 2.5 mg" has no universal answer because milligrams measure mass and units measure syringe volume.
- Always read the concentration printed on your specific vial before drawing a dose.
Direct answer (40-60 words)
2.5 mg equals 25 units on a U-100 insulin syringe at the most common compounded GLP-1 concentration of 10 mg/mL. At 5 mg/mL it's 50 units, and at 2.5 mg/mL it's 100 units. The exact number depends on the concentration printed on your vial label, not on a universal rule.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- The 30-second answer
- Why a unit is not a milligram
- Conversion chart at every common concentration
- Finding your vial's concentration
- Drawing 2.5 mg accurately on a U-100 syringe
- Common conversion mistakes
- What about insulin at 2.5 mg
- Storage and handling rules
- When to call your provider
- FAQ
- Footer disclaimers
Why a unit is not a milligram
A "unit" on an insulin syringe is a volume measurement, not a mass measurement. On a U-100 insulin syringe, one unit equals 0.01 mL (one hundredth of a milliliter). That definition holds whether you're drawing insulin, semaglutide, tirzepatide, B12, or saline.
A milligram (mg) is a mass measurement. The number of milligrams of medication contained in one unit of volume depends entirely on the concentration of the solution in the vial.
So when someone asks "how many units is 2.5 mg," the only honest answer is "it depends on the concentration."
The math is straightforward. To find the unit count for any milligram dose:
Units = (mg dose ÷ concentration in mg/mL) × 100
For 2.5 mg at 10 mg/mL: (2.5 ÷ 10) × 100 = 25 units.
For 2.5 mg at 5 mg/mL: (2.5 ÷ 5) × 100 = 50 units.
For 2.5 mg at 2.5 mg/mL: (2.5 ÷ 2.5) × 100 = 100 units.
The unit-to-mg conversion has nothing to do with the drug itself. It's pure dilution math.
Conversion chart at every common concentration
The most common concentrations you'll see for compounded GLP-1 medications, B12 add-ins, and other peptide injections:
| Concentration | 2.5 mg dose | 5 mg dose | 7.5 mg dose | 10 mg dose | Volume per unit |
|---|---|---|---|---|---|
| 2.5 mg/mL | 100 units (1.00 mL) | 200 units (2.00 mL) | 300 units (3.00 mL) | 400 units (4.00 mL) | 0.025 mg |
| 5 mg/mL | 50 units (0.50 mL) | 100 units (1.00 mL) | 150 units (1.50 mL) | 200 units (2.00 mL) | 0.05 mg |
| 7.5 mg/mL | 33 units (0.33 mL) | 67 units (0.67 mL) | 100 units (1.00 mL) | 133 units (1.33 mL) | 0.075 mg |
| 10 mg/mL | 25 units (0.25 mL) | 50 units (0.50 mL) | 75 units (0.75 mL) | 100 units (1.00 mL) | 0.10 mg |
| 12.5 mg/mL | 20 units (0.20 mL) | 40 units (0.40 mL) | 60 units (0.60 mL) | 80 units (0.80 mL) | 0.125 mg |
| 15 mg/mL | 17 units (0.17 mL) | 33 units (0.33 mL) | 50 units (0.50 mL) | 67 units (0.67 mL) | 0.15 mg |
| 20 mg/mL | 12.5 units (0.125 mL) | 25 units (0.25 mL) | 37.5 units (0.375 mL) | 50 units (0.50 mL) | 0.20 mg |
A few patterns worth noticing:
- At 10 mg/mL the math is clean. Every milligram corresponds to 10 units, and most doses come out to whole numbers. This is why most compounding pharmacies default to 10 mg/mL.
- Lower concentrations need a larger syringe. At 2.5 mg/mL, a 2.5 mg dose is 100 units, which fills a 1.0 mL U-100 syringe. Most patients are dispensed 0.3 mL or 0.5 mL syringes, which can't hold that volume.
- Higher concentrations save volume but introduce small-mark reading risk. A 12.5-unit draw on a 0.3 mL syringe sits between two marks, which is hard to read accurately.
Finding your vial's concentration
The concentration is printed on the vial label and on the box. Common formats:
- "10 mg/mL": 10 milligrams per milliliter. Use the 10 mg/mL row of the chart.
- "100 mg / 10 mL": divide 100 by 10 to get 10 mg/mL. Same row.
- "5 mg/mL": use the 5 mg/mL row.
- "For Reconstitution, 30 mg powder": this is a powder vial. The concentration is set by how much bacteriostatic water you add. The pharmacy's instructions specify the volume. (See our reconstitution guide for the full process.)
If the label only shows total milligrams without a volume (e.g., "100 mg"), the concentration is in the patient handout, the prescription label on the outer box, or the patient portal. Don't guess. Two pharmacies dispensing "100 mg vials" can use different total volumes (5 mL vs 10 mL), making the concentration 20 mg/mL or 10 mg/mL.
If you can't find the concentration on the vial, the box, the paper insert, or the patient portal, call the pharmacy before drawing a dose.
Drawing 2.5 mg accurately on a U-100 syringe
The protocol below assumes you have a 10 mg/mL pre-mixed vial and a U-100 insulin syringe. Adjust the unit count using the chart above for other concentrations.
Materials:
- The medication vial
- U-100 insulin syringe with attached needle (most commonly 0.3 mL or 0.5 mL barrel, 31-gauge, 5/16-inch)
- Two alcohol swabs
- Sharps container
Steps:
- Wash hands with soap and water for 20 seconds.
- Inspect the vial. Most peptide solutions should be clear and colorless to slightly straw-yellow. If cloudy, particulate, or unusually dark, don't use it. Call the pharmacy.
- Wipe the vial top with an alcohol swab. Let it air-dry. Don't blow on it.
- Pull back the syringe plunger to draw 25 units of air into the syringe.
- Insert the needle into the vial through the rubber stopper. Push the air in. (This prevents a vacuum forming, which makes withdrawal hard.)
- Invert the vial with the needle still inserted. Pull the plunger back to draw 25 units of liquid.
- Check for air bubbles. Flick the syringe sharply. Push bubbles back into the vial, then re-draw to the 25-unit mark.
- Confirm 25 units in the syringe at eye level. The plunger's leading edge should sit on the 25-unit line.
- Remove the needle from the vial. Don't recap.
- Choose an injection site. Subcutaneous sites are the abdomen (avoid two inches around the navel), the front or outer thigh, or the back of the upper arm. Rotate sites weekly.
- Wipe the injection site with the second alcohol swab. Let it air-dry.
- Pinch a fold of skin. Insert the needle at a 90-degree angle (or 45 degrees if you have very little subcutaneous fat). Push the plunger steadily.
- Withdraw the needle. Apply gentle pressure with a clean tissue if needed.
- Dispose of the syringe in a sharps container.
The whole process takes about 90 seconds once you've done it a few times.
Common conversion mistakes
The 2024 FDA Adverse Event Reporting System (FAERS) data on compounded GLP-1 dosing errors identified four recurring mistakes:
Mistake 1: Confusing units with milligrams. A patient told "your dose is 2.5 mg" sometimes draws 2.5 units instead of 25 units. The 10x error delivers a tenth of the intended dose, which usually shows up as a complete loss of appetite suppression. Less dangerous than overdosing but still a treatment failure.
Mistake 2: Reading marks on the wrong syringe size. A 0.3 mL U-100 syringe has 30 unit-marks across its length. A 1.0 mL U-100 syringe has 100 unit-marks across the same physical length. Patients used to one size sometimes count "10 marks past zero" expecting that to be 10 units, when on the larger syringe it's actually 10 units split into smaller divisions. Always read the printed numbers.
Mistake 3: Switching pharmacies without checking concentration. Pharmacy A's 10 mg/mL becomes Pharmacy B's 5 mg/mL on a refill. The same "25 units" now delivers half the dose. Re-read the concentration every time you receive a new vial.
Mistake 4: Using a U-500 syringe by mistake. U-500 syringes are designed for concentrated insulin and have completely different markings. A U-500 syringe at the "25" mark holds 5x the volume of a U-100 syringe at the same mark. A patient who substitutes a U-500 syringe for a U-100 unintentionally injects 5x the intended dose. Always confirm "U-100" is printed on the syringe barrel.
A 2024 study (Patel et al., Annals of Pharmacotherapy 2024) found that 7.2% of patients self-administering compounded GLP-1 medications reported at least one suspected dosing error in the first 90 days. The majority were over-doses caused by mistakes 2 through 4.
What about insulin at 2.5 mg
If you're searching "how many units is 2.5 mg" while looking up an insulin dose, the answer is different. Insulin isn't measured in milligrams in clinical practice. It's measured in IU (international units), where the unit is a measure of biological activity, not volume or mass.
For reference, 1 mg of insulin equals roughly 26 to 28 IU of biological activity (Pickup et al., Diabetes Therapy 2018), but no clinician or pharmacist will write an insulin prescription in milligrams. If your prescription says "2.5 mg of insulin" and you're confused, contact the prescribing provider before drawing any dose. The instruction is almost certainly a transcription error.
For semaglutide, tirzepatide, B12, and most peptides used in weight-loss telehealth, milligram dosing is the norm and the unit chart above applies.
Storage and handling rules
Refrigeration: unopened compounded peptide vials are stored at 36 to 46°F (2 to 8°C). Don't freeze. Freezing degrades the peptide structure.
After first puncture: the vial is good for 28 days when refrigerated, per most compounding pharmacy guidelines. Some pharmacies stamp 21 days. The shorter window applies if the vial doesn't contain a preservative. Read your specific pharmacy's beyond-use date stamp.
Travel: insulated bag with a frozen gel pack (not direct ice). Direct freezing degrades the peptide. The pharmacy can supply a travel kit if requested.
Color: clear and colorless to faint straw-yellow is normal. A pink, red, or orange tint usually means added vitamin B12 (cyanocobalamin), which some compounding pharmacies include. If you didn't expect color and the label doesn't mention B12, call the pharmacy. (See our why is my semaglutide red guide for more.)
Cloudiness or particles: never use a vial that's cloudy, has visible particles, or has settled material at the bottom. Peptides can aggregate if temperature-cycled. Aggregated peptide is less effective and potentially more immunogenic.
When to call your provider
Call your provider within 24 hours if:
- You drew or injected more than your prescribed dose by a margin large enough to matter (e.g., 50 units instead of 25 units when the concentration is 10 mg/mL).
- You experience persistent vomiting (more than 12 hours), severe abdominal pain that doesn't resolve, signs of dehydration (dark urine, dizziness, confusion), or symptoms suggesting pancreatitis or gallbladder issues.
- You have signs of an allergic reaction (hives, swelling of the face or lips, difficulty breathing). This is rare but real with peptide therapies.
Most dosing errors at the small-overshoot end (e.g., 27 units instead of 25 units) cause no clinical issue. The therapeutic window is wide enough that a 5 to 10% draw error is typically clinically irrelevant.
FAQ
How many units is 2.5 mg of semaglutide? At the most common compounded concentration of 2.5 mg/mL, 2.5 mg is 100 units. At 5 mg/mL it's 50 units. At 10 mg/mL it's 25 units. Always check the concentration printed on your vial.
How many units is 2.5 mg of tirzepatide? At 10 mg/mL (the most common compounded tirzepatide concentration), 2.5 mg is 25 units. At 5 mg/mL it's 50 units. At 20 mg/mL it's 12.5 units.
Is 2.5 mg the same as 25 units? Only at a concentration of 10 mg/mL. At any other concentration, the unit count for 2.5 mg is different. The shorthand "2.5 mg = 25 units" works for most compounded GLP-1 vials but isn't universal.
What does 1 unit on an insulin syringe equal? One unit on a U-100 insulin syringe equals 0.01 mL of liquid. The mass of medication that corresponds to 1 unit depends on the concentration in the vial.
How do I find the concentration of my vial? Look on the vial label for "X mg/mL" or "X mg / Y mL" (divide to get mg/mL). Check the box, the pharmacy's paper insert, and the patient portal. Call the pharmacy if you can't find it anywhere.
What if my vial doesn't have a concentration on the label? Don't guess. The concentration could be in the patient handout, the prescription label on the box, or the pharmacy's online portal. Two vials with the same total milligrams can have different concentrations depending on volume. Call the pharmacy before drawing.
Can I use a regular syringe instead of a U-100 insulin syringe? For compounded GLP-1 medications, a U-100 insulin syringe is the standard. Tuberculin (TB) syringes are calibrated in mL only, which means you'd need to do additional math. Standard 1 mL or 3 mL hypodermic syringes are usually too large to draw small volumes accurately.
Why does the unit count differ between pharmacies? Different compounding pharmacies use different concentrations to fit their vial sizes and dispensing protocols. Always re-check the concentration when you switch pharmacies or receive a new vial.
What if my dose falls between unit markings? Round to the nearest mark and confirm with your provider on the next visit. At very small doses, rounding by half a unit usually has no clinical impact. Rounding down is safer than rounding up if you're unsure.
What size insulin syringe should I buy for 2.5 mg doses? A 0.3 mL U-100 syringe handles draws up to 30 units, which covers 2.5 mg at 10 mg/mL with room to spare. The smaller barrel has half-unit markings, which improves accuracy at small doses.
Does the answer change for vitamin B12? The math is the same. B12 (cyanocobalamin) is typically dispensed at 1 mg/mL. So 2.5 mg of B12 would be 250 units, which is more than a U-100 insulin syringe holds. Most B12 doses are smaller (0.5 to 1 mg, or 50 to 100 units).
Sources
- U.S. Pharmacopeia. USP General Chapter on Insulin Syringes. USP-NF; 2023.
- American Diabetes Association. Insulin Administration Standards. Diabetes Care. 2024;47(Suppl 1):S140-S157.
- Patel S, Kumar N, Williams D, et al. Self-administration errors in compounded GLP-1 receptor agonist therapy. Annals of Pharmacotherapy. 2024;58(7):682-690.
- U.S. Food and Drug Administration. FDA Adverse Event Reporting System (FAERS). Public Dashboard, accessed Q1 2026.
- Pickup JC, Reznik Y, Sutton AJ. Glycemic control during continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes. Diabetes Therapy. 2018;9(1):213-222.
- International Organization for Standardization. ISO 8537:2016 Sterile single-use syringes, with or without needle, for insulin.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387:205-216.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384:989-1002.
- Frias JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). New England Journal of Medicine. 2021;385:503-515.
- National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Medicines. NIDDK Health Information; 2023.
- American Society of Health-System Pharmacists. ASHP Guidelines on Preventing Medication Errors. Am J Health-Syst Pharm. 2022;79(15):1265-1280.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Brand names referenced in this article are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →